Utah Retirement Systems’s Bristol-Myers Squibb BMY Stock Holding History

Utah Retirement Systems’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$20.1M	Sell	331,182 -5,499	-2%	-$321K	0.21%	86
2025 Q4	$18.2M	Hold	336,681	–	–	0.17%	106
2025 Q3	$15.2M	Buy	336,681 +1,821	+0.5%	+$85K	0.15%	127
2025 Q2	$15.5M	Sell	334,860 -1,030	-0.3%	-$50.6K	0.16%	120
2025 Q1	$20.5M	Sell	335,890 -540	-0.2%	-$31.5K	0.24%	86
2024 Q4	$19M	Buy	336,430 +900	+0.3%	+$50.3K	0.21%	87
2024 Q3	$17.4M	Buy	335,530 +1,300	+0.4%	+$61K	0.2%	100
2024 Q2	$13.9M	Sell	334,230 -18,800	-5%	-$841K	0.16%	117
2024 Q1	$19.1M	Sell	353,030 -200	-0.1%	-$10.2K	0.22%	87
2023 Q4	$18.1M	Sell	353,230 -9,200	-3%	-$483K	0.23%	88
2023 Q3	$21M	Buy	362,430 +1,500	+0.4%	+$91.9K	0.3%	61
2023 Q2	$23.1M	Sell	360,930 -18,500	-5%	-$1.24M	0.32%	55
2023 Q1	$26.3M	Buy	379,430 +1,200	+0.3%	+$84.6K	0.38%	47
2022 Q4	$27.2M	Sell	378,230 -3,600	-0.9%	-$271K	0.43%	42
2022 Q3	$27.1M	Buy	381,830 +1,800	+0.5%	+$131K	0.45%	39
2022 Q2	$29.3M	Sell	380,030 -9,200	-2%	-$701K	0.47%	39
2022 Q1	$28.4M	Sell	389,230 -16,100	-4%	-$1.08M	0.38%	50
2021 Q4	$25.3M	Buy	405,330 +900	+0.2%	+$52.8K	0.31%	58
2021 Q3	$23.9M	Sell	404,430 -21,500	-5%	-$1.42M	0.32%	57
2021 Q2	$28.5M	Sell	425,930 -9,100	-2%	-$593K	0.37%	52
2021 Q1	$27.5M	Sell	435,030 -19,100	-4%	-$1.19M	0.38%	54
2020 Q4	$28.2M	Buy	454,130 +19,500	+4%	+$1.2M	0.4%	50
2020 Q3	$26.2M	Buy	434,630 +2,900	+0.7%	+$175K	0.43%	44
2020 Q2	$25.4M	Sell	431,730 -14,500	-3%	-$867K	0.47%	43
2020 Q1	$24.9M	Sell	446,230 -100	-0%	-$6.11K	0.54%	34
2019 Q4	$28.6M	Buy	446,330 +135,273	+43%	+$7.75M	0.5%	34
2019 Q3	$15.8M	Buy	311,057 +1,300	+0.4%	+$61.1K	0.3%	66
2019 Q2	$14M	Buy	309,757 +778	+0.3%	+$36.2K	0.27%	72
2019 Q1	$14.7M	Buy	308,979 +3,917	+1%	+$195K	0.29%	67
2018 Q4	$15.9M	Buy	305,062 +700	+0.2%	+$37.6K	0.36%	58
2018 Q3	$18.9M	Buy	304,362 +1,400	+0.5%	+$83.1K	0.37%	58
2018 Q2	$16.8M	Sell	302,962 -4,100	-1%	-$221K	0.35%	60
2018 Q1	$19.4M	Buy	307,062 +500	+0.2%	+$32.2K	0.41%	48
2017 Q4	$18.8M	Buy	306,562 +4,200	+1%	+$263K	0.39%	48
2017 Q3	$19.3M	Buy	302,362 +300	+0.1%	+$17.5K	0.43%	46
2017 Q2	$16.8M	Sell	302,062 -4,100	-1%	-$223K	0.39%	47
2017 Q1	$16.6M	Buy	306,162 +200	+0.1%	+$11K	0.4%	45
2016 Q4	$17.9M	Hold	305,962	–	–	0.45%	42
2016 Q3	$16.5M	Hold	305,962	–	–	0.43%	46
2016 Q2	$22.5M	Buy	305,962 +5,800	+2%	+$410K	0.6%	33
2016 Q1	$19.2M	Buy	300,162 +1,100	+0.4%	+$69.4K	0.52%	40
2015 Q4	$20.6M	Buy	299,062 +600	+0.2%	+$39.6K	0.56%	35
2015 Q3	$17.7M	Buy	298,462 +1,600	+0.5%	+$102K	0.51%	38
2015 Q2	$19.8M	Buy	296,862 +600	+0.2%	+$39.5K	0.53%	38
2015 Q1	$19.1M	Buy	296,262 +9,500	+3%	+$595K	0.5%	43
2014 Q4	$16.9M	Hold	286,762	–	–	0.47%	43
2014 Q3	$14.7M	Sell	286,762 -700	-0.2%	-$35K	0.42%	45
2014 Q2	$13.9M	Sell	287,462 -7,500	-3%	-$370K	0.4%	47
2014 Q1	$15.3M	Buy	294,962 +2,000	+0.7%	+$106K	0.44%	45
2013 Q4	$15.6M	Hold	292,962	–	–	0.46%	41
2013 Q3	$13.6M	Sell	292,962 -2,400	-0.8%	-$105K	0.44%	42
2013 Q2	$13.2M	Buy	+295,362	New	+$12.8M	0.45%	40

Other funds holding BMY

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Utah Retirement Systems's BMY Position: Q1 2026 in Review

Utah Retirement Systems reduced its Bristol-Myers Squibb (BMY) stake by 1.6% in Q1 2026, selling an estimated $321K and leaving 331,182 shares worth $20.1M. The position accounts for 0.21% of the portfolio, ranked #86.

Utah Retirement Systems first reported a position in BMY in Q2 2013 and has held it in 52 quarters since. The position peaked at $29.3M in Q2 2022. 2,520 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

Utah Retirement Systems held 331,182 shares of Bristol-Myers Squibb worth $20.1M as of Q1 2026.
Utah Retirement Systems sold 5,499 Bristol-Myers Squibb shares in Q1 2026, an estimated $321K.
Bristol-Myers Squibb made up 0.21% of Utah Retirement Systems's portfolio in Q1 2026, its #86 holding.
Utah Retirement Systems first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 52 quarters since.
Utah Retirement Systems's Bristol-Myers Squibb position peaked at $29.3M in Q2 2022.
2,520 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Utah Retirement Systems's 13F filing for Q1 2026, filed 15 May 2026.